Jiali Xu

3.0k total citations · 1 hit paper
157 papers, 2.1k citations indexed

About

Jiali Xu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Jiali Xu has authored 157 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 33 papers in Oncology and 33 papers in Cancer Research. Recurrent topics in Jiali Xu's work include MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (13 papers) and Lung Cancer Treatments and Mutations (11 papers). Jiali Xu is often cited by papers focused on MicroRNA in disease regulation (13 papers), Cancer-related molecular mechanisms research (13 papers) and Lung Cancer Treatments and Mutations (11 papers). Jiali Xu collaborates with scholars based in China, United States and Taiwan. Jiali Xu's co-authors include Xuemei Jia, Zhiqiang Yin, Lingxiang Liu, Yongmei Yin, Yongqian Shu, Wen Gao, Weicheng Bei, Dan Luo, Huanchun Chen and Chengkun Zheng and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Jiali Xu

142 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer-associated fibroblasts promote EGFR-TKI resistance via the CTHRC1/glycolysis/H3K18la positive feedback loop

2025 19 citations Chen Zhang, Wenxin Zhou et al. profile →

Peers

Jiali Xu

MB

CR

ONCOL

IMMUN

PRM

Ting Li China

Jae Hyang Lim South Korea

Mohamed F. Elshal Egypt

Xing Zhang China

Fan Yang China

Francesca Rappa Italy

Théo Klein Netherlands

Yuanyuan Wang China

Ziwei Li China

Yili Wang China

Ting Li China

Jiali Xu

1.8k ×1.9

MB

826 ×1.5

CR

407 ×1.0

ONCOL

295 ×1.0

IMMUN

221 ×0.8

PRM

Citations per year, relative to Jiali Xu Jiali Xu (= 1×) peers Ting Li

Countries citing papers authored by Jiali Xu

Since Specialization

Citations

This map shows the geographic impact of Jiali Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiali Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiali Xu more than expected).

Fields of papers citing papers by Jiali Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiali Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiali Xu. The network helps show where Jiali Xu may publish in the future.

Co-authorship network of co-authors of Jiali Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Jiali Xu. A scholar is included among the top collaborators of Jiali Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiali Xu. Jiali Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Liang, Xiaowen, Jiali Xu, Songren Shu, et al.. (2025). GLMP promotes EGFR-TKI resistance by activating autophagy and RhoA pathway in non-small cell lung cancer. npj Precision Oncology. 9(1). 391–391.

2.

Wang, Fang, Shuiping Dai, Jiali Xu, et al.. (2025). Soy protein isolate/dextran glycation conjugates: Fabrication through ultrasound-assisted cyclic continuous reaction and their applications as carriers of anthocyanins. International Journal of Biological Macromolecules. 294. 139485–139485. 6 indexed citations

3.

Zhu, Yuting, Xiao Liang, Rong Huang, et al.. (2025). Third‐Generation EGFR ‐ TKIs Combined With Chemotherapy in Advanced Non‐Small Cell Lung Cancer: A Real‐World Study. Cancer Science. 117(2). 476–490.

4.

Zhang, Liping, Mingjie Luo, Yu Cheng, et al.. (2025). Both direct and indirect suppression of MCL1 synergizes with BCLXL inhibition in preclinical models of gastric cancer. Cell Death and Disease. 16(1). 170–170. 3 indexed citations

5.

Li, Yuanyuan, Qunying Hu, Jiali Xu, et al.. (2025). Hydrogen sulfide as a therapeutic agent for diabetic wounds: effects on inflammation and fibroblast pyroptosis. Frontiers in Immunology. 16. 1558443–1558443. 1 indexed citations

6.

Xiao, Liang, Jiali Xu, Hongshuai Wu, et al.. (2024). Concomitant genomic features stratify prognosis to patients with advanced EGFR mutant lung cancer. Molecular Carcinogenesis. 63(9). 1643–1653. 2 indexed citations

7.

Sun, Jing, Jing Wang, Xin Jiang, et al.. (2024). LADS: a powerful vaccine platform for cancer immunotherapy and prevention. BMC Biology. 22(1). 291–291.

8.

Xu, Jiali, et al.. (2024). Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases. Clinical Neurology and Neurosurgery. 240. 108258–108258. 1 indexed citations

9.

Xu, Jiali, et al.. (2023). A novel nonsynonymous SNP in the OLR1 gene associated with litter size in Guizhou white goats. Theriogenology. 200. 1–10. 3 indexed citations

10.

Lu, Xiyi, et al.. (2023). Carbonic Anhydrase IX Controls Vulnerability to Ferroptosis in Gefitinib-Resistant Lung Cancer. Oxidative Medicine and Cellular Longevity. 2023. 1–21. 14 indexed citations

11.

Xu, Jiali, et al.. (2023). Effect of Bovine MEF2A Gene Expression on Proliferation and Apoptosis of Myoblast Cells. Genes. 14(7). 1498–1498. 3 indexed citations

12.

Gao, Peng, Chenzhi Wang, Jiali Xu, Shanling Liu, & Lan Zhou. (2023). Role of selenium in cell death. 8(2). 94–100. 4 indexed citations

13.

Li, Qing, Liren Zhang, Wenhua You, et al.. (2022). PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells. Nature Communications. 13(1). 7677–7677. 61 indexed citations

14.

Jiang, Huning, Jiahua Cui, Tingting Xu, et al.. (2022). Targeting IL8 as a sequential therapy strategy to overcome chemotherapy resistance in advanced gastric cancer. Cell Death Discovery. 8(1). 235–235. 13 indexed citations

15.

Wang, Haizhou, Fan Wang, Xiaoxia Lü, et al.. (2021). Co-infections of SARS-CoV-2 with multiple common respiratory pathogens in infected children. Medicine. 100(11). e24315–e24315. 30 indexed citations

16.

Cheng, Changyong, Xiao Han, Jiali Xu, et al.. (2021). YjbH mediates the oxidative stress response and infection by regulating SpxA1 and the phosphoenolpyruvate-carbohydrate phosphotransferase system (PTS) in Listeria monocytogenes. Gut Microbes. 13(1). 1–19. 13 indexed citations

17.

Li, Zhiwei, Jiali Xu, Chen Tan, et al.. (2018). A Streptococcus suis Live Vaccine Suppresses Streptococcal Toxic Shock-Like Syndrome and Provides Sequence Type-Independent Protection. The Journal of Infectious Diseases. 219(3). 448–458. 10 indexed citations

18.

Xu, Jiali, et al.. (2018). [Effects of honokiol on particulate matter 2.5-induced lung injury in asthmatic mice and its mechanisms].. PubMed. 43(7). 718–724. 5 indexed citations

19.

Hu, Yingying, Li Yin, Jiali Xu, & Zhiqiang Yin. (2017). Renal function of psoriatic patients: erythrodermic psoriasis has more significant hyperuricemia. Biomedical Research-tokyo. 28(6). 2515–2518. 2 indexed citations

20.

Wu, Kai, Yang Yu, Jiali Xu, et al.. (2017). MicroRNA-34a modulates the Notch signaling pathway in mice with congenital heart disease and its role in heart development. Journal of Molecular and Cellular Cardiology. 114. 300–308. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact